London Stock Exchange Q3 Total Income Rises; Confirms FY21 View - Quick Facts

London Stock Exchange Group plc (LSE.L) reported Friday that its third-quarter total income, excluding recoveries, grew 1.7 percent to 1.693 billion pounds from last year's 1.665 billion pounds.

Constant Currency growth was 7.5 percent, while income growth was 7.6 percent on a pro-forma constant currency basis, excluding the impact of a deferred revenue accounting adjustment.

Including recoveries, total income was 1.783 billion pounds, up 2.1 percent from 1.747 billion pounds last year. Constant Currency growth was 7.1 percent, while Constant Currency growth excluding deferred revenue adjustment was 7.2 percent.

The results reflected srong performance across all divisions.

Gross profit grew 2.4 percent on a reported basis and 7.2 percent at constant rates to 1.56 billion pounds.

Data & Analytics revenue grew 6.0 percent, Capital Markets revenue grew 17.2 percent, and Post Trade revenue increased 11.5 percent.

Looking ahead, the company said it continues to expect total income to grow between 4-5 percent for full year 2021, with fourth-quarter income not expected to grow as fast as Q3 on a constant currency basis due to the strong comparator in Q4 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Privately-held biotechnology company On Target Laboratories, Inc. announce that the U.S. Food and Drug Administration or FDA, has approved Cytalux (pafolacianine) for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. Cytalux is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively. The Federal Trade Commission or FTC has ordered Walmart, Amazon, Kroger and certain other large wholesalers and suppliers to provide information to help it study causes of supply chain disruptions. The agency has launched an inquiry to find the reasons for empty shelves and exorbitant prices. Along with Walmart, Amazon.com, and Kroger, the order has been sent to C&S Wholesale Grocers, Associated.. Covid vaccine maker Moderna Inc.'s Chief Executive Stéphane Bancel has predicted that existing COVID-19 vaccines will be much less effective against Omicron than earlier strains, according to the Financial Times.
Follow RTT